The OPTIMIST study: optimisation of cost effectiveness through individualised FSH stimulation dosages for IVF treatment. A randomised controlled trial

Autor: van Tilborg Theodora C, Eijkemans Marinus JC, Laven Joop SE, Koks Carolien AM, de Bruin Jan, Scheffer Gabrielle J, van Golde Ron JT, Fleischer Kathrin, Hoek Annemieke, Nap Annemiek W, Kuchenbecker Walter KH, Manger Petra A, Brinkhuis Egbert A, van Heusden Arne M, Sluijmer Alexander V, Verhoeff Arie, van Hooff Marcel HA, Friederich Jaap, Smeenk Jesper MJ, Kwee Janet, Verhoeve Harold R, Lambalk Cornelis B, Helmerhorst Frans M, van der Veen Fulco, Mol Ben Willem J, Torrance Helen L, Broekmans Frank JM

Publikováno v: BMC Women's Health, Vol 12, Iss 1, p 29 (2012)

Abstract Background Costs of in vitro fertilisation (IVF) are high, which is partly due to the use of follicle stimulating hormone (FSH). FSH is usually administered in a standard dose. However, due to differences in ovarian reserve between women, ov

Externí odkaz: https://doaj.org/article/d2ee761780044a36abf3e5f4d1cdd670

Do female age and body weight modify the effect of individualized FSH dosing in IVF/ICSI treatment? A secondary analysis of the OPTIMIST trial

Autor: Leijdekkers, Jori A., van Tilborg, Theodora C., Torrance, Helen L., Oudshoorn, Simone C., Brinkhuis, Egbert A., Koks, Carolien A. M., Lambalk, Cornelis B., de Bruin, Jan Peter, Fleischer, Kathrin, Mochtar, Monique H., Kuchenbecker, Walter K. H., Laven, Joop S. E., Mol, Ben Willem J., Broekmans, Frank J. M., Eijkemans, Marinus J. C., van Golde, Ron J. T., Verhoeve, Harold R., Nap, Annemiek W., Scheffer, Gabrielle J., Manger, A. Petra, Hoek, Annemieke, Schoot, Bendictus C., Oosterhuis, G. Jur E., Sluijmer, Alexander V., Friederich, Jaap, Verhoeff, Arie, van Hooff, Marcel H. A., van Santbrink, Evert J. P., Smeenk, Jesper M. J., Kwee, Janet, de Koning, Corry H., Groen, Henk, van Wely, Madelon

Publikováno v: Acta obstetricia et gynecologica Scandinavica, 98(10), 1332-1340. Wiley-Blackwell
Leijdekkers, J A, van Tilborg, T C, Torrance, H L, Oudshoorn, S C, Brinkhuis, E A, Koks, C A M, Lambalk, C B, de Bruin, J P, Fleischer, K, Mochtar, M H, Kuchenbecker, W K H, Laven, J S E, Mol, B W J, Broekmans, F J M, Eijkemans, M J C & the OPTIMIST study group 2019, ' Do female age and body weight modify the effect of individualized FSH dosing in IVF/ICSI treatment? A secondary analysis of the OPTIMIST trial ', Acta Obstetricia et Gynecologica Scandinavica, vol. 98, no. 10, pp. 1332-1340 . https://doi.org/10.1111/aogs.13664
Acta Obstetricia et Gynecologica Scandinavica, 98, 1332-1340
Acta Obstetricia et Gynecologica Scandinavica, 98(10), 1332-1340. Wiley-Blackwell
Acta Obstetricia et Gynecologica Scandinavica, 98(10), 1332-1340. Wiley
Acta Obstetricia et Gynecologica Scandinavica, 98, 10, pp. 1332-1340
Acta Obstetricia et Gynecologica Scandinavica, 98(10), 1332. Wiley-Blackwell

Introduction: The OPTIMIST trial revealed that for women starting in vitro fertilization (IVF)/intracytoplasmic sperm injection (ICSI) treatment, no substantial differences exist in first cycle and cumulative live birth rates between an antral follic

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a8e1d6164ab7e7b7f632a6862fa0011
https://pubmed.ncbi.nlm.nih.gov/31127607

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Single-Dose Oral Fluconazole Versus Single-Dose Topical Miconazole for the Treatment of Acute Vulvovaginal Candidosis

Autor: van Heusden, Arne, Merkus, Hans, Corbeij, Ruud, Oosterbaan, Herman, Stoot, Jan, Ubachs, Hans, Verhoeff, Arie

Publikováno v: Acta Obstetricia et Gynecologica Scandinavica; 1990, Vol. 69 Issue: 5 p417-422, 6p